Send to

Choose Destination
See comment in PubMed Commons below
Eur J Pharmacol. 2003 Jan 5;458(3):327-8.

Beneficial effect of pharmacological mobilization of bone marrow in experimental cerebral ischemia.

Author information

  • 1EA1046-Laboratoire de Pharmacologie, Faculté de Médecine, Université de Lille 2, France.


Bone marrow stem cells are able to differentiate into nervous and endothelial cells. In our study, we found that administration of a bone marrow-stimulating factor (granulocyte colony-stimulating factor; G-CSF 50 microg/kg) decrease the brain infarct volume and enhance survival rate in a model of cerebral ischemia. Taken together, these data suggest a beneficial effect of a pharmacological endogenous bone marrow mobilization in the course of cerebral ischemia and open a new direction for cellular therapy strategy in stroke.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center